Abstract
ObjectiveTo evaluate the effectiveness and cost-effectiveness of the National PReCePT Programme (NPP) in increasing use of magnesium sulfate (MgSO4) in preterm births.DesignBefore-and-after study.SettingMaternity units (N=137) within NHS England and the Academic Health Science Network (AHSN) in 2018.ParticipantsBabies born ≤30 weeks’ gestation admitted to neonatal units in England.InterventionsThe NPP was a quality improvement (QI) intervention including the PReCePT (Preventing Cerebral Palsy in Pre Term labour) QI toolkit and materials (preterm labour proforma, staff training presentations, parent leaflet, posters for the unit and learning log), regional AHSN-level support, and up to 90 hours funded backfill for a midwife ‘champion’ to lead implementation.Main outcome measuresMgSO4uptake post implementation was compared with pre-NPP implementation uptake. Implementation and lifetime costs were estimated.ResultsCompared with pre-implementation estimates, the average MgSO4uptake for babies born ≤30 weeks’ gestation, in 137 maternity units in England, increased by 6.3 percentage points (95% CI 2.6 to 10.0 percentage points) to 83.1% post implementation, accounting for unit size, maternal, baby and maternity unit factors, time trends, and AHSN. Further adjustment for early/late initiation of NPP activities increased the estimate to 9.5 percentage points (95% CI 4.3 to 14.7 percentage points). From a societal and lifetime perspective, the health gains and cost savings associated with the NPP effectiveness generated a net monetary benefit of £866 per preterm baby and the probability of the NPP being cost-effective was greater than 95%.ConclusionThis national QI programme was effective and cost-effective. National programmes delivered via coordinated regional clinical networks can accelerate uptake of evidence-based therapies in perinatal care.
Funder
National Institute for Health Research Applied Research Collaboration West
Health Foundation
AHSN Network
Subject
Obstetrics and Gynecology,General Medicine,Pediatrics, Perinatology and Child Health
Reference22 articles.
1. National Institute for Health and Care Excellence (NICE) guideline NG25 . Preterm labour and birth NG25. UK NICE; 2015.
2. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus;Doyle;Cochrane Database Syst Rev,2009
3. Economic evaluation and cost of interventions for cerebral palsy: a systematic review;Shih;Dev Med Child Neurol,2018
4. Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis
5. NNAP . National neonatal audit programme (NNAP) annual report 2017. UK RCPCH; 2018.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献